Skip to main content
CRL
NYSE Life Sciences

Charles River Beats Q3, Lifts 2026 Guidance as Non-GAAP EPS Jumps 27%

Tom Rudovsky · Reported by Wiseek News
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$362
Mkt Cap
$16.798B
52W Low
$146.195
52W High
$379.63
52W Position info
148% above low
Off High info
4.6% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

CRL has more than doubled off its 52-week low of $146.195.

Summary

Charles River beat third-quarter expectations and raised its 2026 revenue and EPS guidance, now seeing adjusted EPS of $11.35 to $11.65, up from its prior $11.15 to $11.45, and revenue down 1.5% to 2%, narrowed from a prior down 2.5% to 3.5%. It now expects 2026 organic revenue up at least 1.5%, versus a prior flat to up 1%. Non-GAAP diluted EPS came in at $3.09, up 27.2% year over year, helped partly by a lower tax rate, while net income was $333.1 million. Reported revenue fell 2.2% to $982.7 million, but organic revenue grew 4.7% — the decline was driven primarily by May 2026 divestitures. GAAP EPS of $6.86 includes a $5.06 tax benefit from a reserve reversal, so it overstates recurring performance. This follows the August Q2 beat that triggered a wave of analyst upgrades and the September Investor Day that reaffirmed 2026 guidance at the upper end of ranges; the stock is trading near its 52-week high.

Updates

  1. · SEC 8-K — Charles River's raised 2026 non-GAAP EPS guidance is $11.35-$11.55, with GAAP EPS $8.15-$8.35 including a $5.03 reversal of acquired tax reserves.

At the time of this announcement, CRL was trading at $362.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $16.8B. The 52-week trading range was $146.20 to $379.63. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

CRL - Latest Insights

CRL
Nov 09, 2026, 6:10 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $337.44
Real-time Price: $325.80 info
Change: -$11.64 (-3%) info
Market Cap: $15.714B info
CRL
Nov 04, 2026, 9:03 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $342.99
Real-time Price: $325.80 info
Change: -$17.19 (-5%) info
Market Cap: $15.714B info
CRL
Nov 04, 2026, 7:04 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $362.01
Real-time Price: $325.80 info
Change: -$36.21 (-10%) info
Market Cap: $15.714B info
CRL
Sep 24, 2026, 8:12 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $278.01
Real-time Price: $325.80 info
Change: +$47.79 (+17%) info
Market Cap: $15.714B info
CRL
Sep 24, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $277.33
Real-time Price: $325.80 info
Change: +$48.47 (+17%) info
Market Cap: $15.714B info